VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,448,918 | -30.1% | 130,888 | +2.4% | 0.00% | 0.0% |
Q2 2023 | $2,072,108 | +648.1% | 127,829 | +38.2% | 0.00% | – |
Q1 2022 | $277,000 | -44.7% | 92,483 | -15.1% | 0.00% | -100.0% |
Q4 2021 | $501,000 | -27.2% | 108,882 | -0.6% | 0.00% | 0.0% |
Q3 2021 | $688,000 | +8.2% | 109,528 | +3.2% | 0.00% | 0.0% |
Q2 2021 | $636,000 | -12.4% | 106,150 | -7.5% | 0.00% | 0.0% |
Q1 2021 | $726,000 | +7.2% | 114,751 | -4.6% | 0.00% | 0.0% |
Q4 2020 | $677,000 | +9.0% | 120,261 | +12.7% | 0.00% | 0.0% |
Q3 2020 | $621,000 | -28.7% | 106,683 | -11.7% | 0.00% | 0.0% |
Q2 2020 | $871,000 | +70.1% | 120,772 | +10.4% | 0.00% | 0.0% |
Q1 2020 | $512,000 | -36.6% | 109,358 | +8.7% | 0.00% | 0.0% |
Q4 2019 | $807,000 | +17.8% | 100,608 | +1.0% | 0.00% | 0.0% |
Q3 2019 | $685,000 | -10.1% | 99,622 | +8.5% | 0.00% | 0.0% |
Q2 2019 | $762,000 | -1.4% | 91,819 | +18.1% | 0.00% | 0.0% |
Q1 2019 | $773,000 | +39.0% | 77,757 | +6.9% | 0.00% | 0.0% |
Q4 2018 | $556,000 | -29.0% | 72,740 | +61.9% | 0.00% | -50.0% |
Q3 2018 | $783,000 | +98.2% | 44,941 | +7.9% | 0.00% | +100.0% |
Q2 2018 | $395,000 | – | 41,637 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |